as on November 17, 2025 at 8:36 pm IST
Day's Low
Day's High
0.07%
Downside
1.16%
Upside
52 Week's Low
52 Week's High
37.11%
Downside
19.19%
Upside
Check Ani Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
7.4984
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.17%
PE Ratio (TTM)
52.51
Industry PE ratio
-0.8126129032258065
PEG Ratio
1.06
EBITDA
145.1M
Revenue (TTM)
826.9M
Profit Margin
4.91%
Return On Equity TTM
8.66%
Track how Ani Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Ani Pharmaceuticals Inc in the last 5 years
Lowest (8.18x)
December 31, 2020
Industry (-0.81x)
November 17, 2025
Today (52.51x)
November 17, 2025
Highest (42.03x)
September 30, 2025
Today’s Price to Earnings Ratio: 52.51x
Compare market cap, revenue, PE, and other key metrics of Ani Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.9B | 191.53% | 52.51 | 4.91% | |
| BUY | $20.1B | NA | 17.68 | 40.65% | |
| BUY | $44.0B | NA | 21.8 | 13.81% | |
| BUY | $14.4B | 57.89% | 34.57 | 15.95% | |
| BUY | $53.4B | -26.97% | 20.34 | 28.21% |
The Ani Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ani Pharmaceuticals Inc investment value today
Current value as on today
₹1,52,635
Returns
₹52,635
(+52.63%)
Returns from Ani Pharmaceuticals Inc Stock
₹47,543 (+47.54%)
Dollar Returns*
₹5,091 (+5.09%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ani Pharmaceuticals Inc. Average target price of $109.88
Get share price movements and forecasts by analysts on Ani Pharmaceuticals Inc.
What analysts predicted
24.03%UPSIDE
Target Price
$109.88
Current Price
$83.48
Analyzed by
11 Analysts
Target
$109.88
Ani Pharmaceuticals Inc target price $109.88, a slight upside of 24.03% compared to current price of $83.48. According to 11 analysts rating.
Search interest for Ani Pharmaceuticals Inc Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:27% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 November
Fri, 05:30 PM
-ANI Pharmaceuticals reports strong Q3 results, with revenue up 53.6% to $227.8 million, exceeding analyst expectations.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, ANIP has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 8.54M → 24.13M (in $), with an average increase of 64.6% per quarter
Price Rise
![]()
In the last 6 months, ANIP stock has moved up by 40.1%
Best in 1 Year
![]()
In the last 1 year, ANIP has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 8 quarters, 131.65M → 227.81M (in $), with an average increase of 7.3% per quarter
| Organisation | Ani Pharmaceuticals Inc |
| Headquarters | 210 Main Street West, Baudette, MN, United States, 56623 |
| Industry | Health Technology |
| CEO | Mr. Nikhil Lalwani |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy |
Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer |
Mr. Christopher K. Mutz | Senior VP & Head of Rare Disease |
Mr. Ori Gutwerg | Senior Vice President of Generics |
Mr. Muthusamy Shanmugam MS R.Ph. | Head of R&D, COO of New Jersey Operations & Director |
Ms. Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease |
Mr. Nikhil Lalwani | President, CEO & Director |
Mr. Stephen P. Carey | Senior VP of Finance & CFO |
Ms. Meredith W. Cook J.D. | Senior VP, General Counsel & Corporate Secretary |
Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
Ani Pharmaceuticals Inc share price today is $83.48 as on . Ani Pharmaceuticals Inc share today touched a day high of $84.45 and a low of $83.42.
Ani Pharmaceuticals Inc share touched a 52 week high of $99.5 on and a 52 week low of $52.5 on . Ani Pharmaceuticals Inc stock price today i.e. is trending at $83.48,which is 16.10% down from its 52 week high and 59.01% up from its 52 week low.
Ani Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ani Pharmaceuticals Inc (ANIP) shares with as little as ₹88.613 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.13 in Ani Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ani Pharmaceuticals Inc share’s latest price of $83.48 as on November 17, 2025 at 8:36 pm IST, you will get 0.1198 shares of Ani Pharmaceuticals Inc. Learn more about
fractional shares .
Ani Pharmaceuticals Inc stock has given 191.53% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?